1 | HILPDA
|
| Expression of hypoxia-inducible 2 (HIG2) protein in uterine cancer.
|
| Nishimura S, Tsuda H, Nomura H, Kataoka F, Chiyoda T, Tanaka H, Tanaka K, Susumu N, Aoki D.
|
| Eur J Gynaecol Oncol 32(2):146-9.
2011
|
2 | DBN1, HILPDA, SETMAR, SOX11
|
| Gene expression profiling and chromatin immunoprecipitation identify DBN1, SETMAR and HIG2 as direct targets of SOX11 in mantle cell lymphoma.
|
| Wang X, Björklund S, Wasik AM, Grandien A, Andersson P, Kimby E, Dahlman-Wright K, Zhao C, Christensson B, Sander B.
|
| PLoS One 5(11):e14085.
2010
|
3 | HILPDA
|
| Hypoxia-inducible protein 2 is a novel lipid droplet protein and a specific target gene of hypoxia-inducible factor-1.
|
| Gimm T, Wiese M, Teschemacher B, Deggerich A, Schödel J, Knaup KX, Hackenbeck T, Hellerbrand C, Amann K, Wiesener MS, Höning S, Eckardt KU, Warnecke C.
|
| FASEB J 24(11):4443-58. Epub 2010 Jul 12.
2010
|
4 | HILPDA
|
| Differential expression of hypoxia-inducible protein 2 among different histological types of epithelial ovarian cancer and in clear cell adenocarcinomas.
|
| Nishimura S, Tsuda H, Ito K, Takano M, Terai Y, Jobo T, Kigawa J, Sugiyama T, Yaegashi N, Aoki D.
|
| Int J Gynecol Cancer 20(2):220-6.
2010
|
5 | HILPDA
|
| Hypoxia-inducible protein 2 (HIG2), a novel diagnostic marker for renal cell carcinoma and potential target for molecular therapy.
|
| Togashi A, Katagiri T, Ashida S, Fujioka T, Maruyama O, Wakumoto Y, Sakamoto Y, Fujime M, Kawachi Y, Shuin T, Nakamura Y.
|
| Cancer Res 65(11):4817-26. 2005
|
6 | HILPDA
|
| Epigenetic regulation of gene expression in cervical cancer cells by the tumor microenvironment.
|
| Denko N, Schindler C, Koong A, Laderoute K, Green C, Giaccia A.
|
| Clin Cancer Res 6(2):480-7. 2000
|